CD4 and neoplasm: There is increasing evidence that immune cell infiltration can influence tumor progression and recurrence and become an important determinant of immunotherapeutic response and clinical outcome [26].CD4+ T cells recognize cancer antigens, while macrophages may be involved in tumor inhibition [27].